clinical trial · NCT06391177
A Study to Evaluate Vonoprazan Concentrations in Breast Milk of Healthy Lactating Women Receiving Vonoprazan 20 mg Once Daily or Vonoprazan 20 mg Twice Daily
Erosive EsophagitisHeartburnSymptomatic Nonerosive Gasroesophageal Reflux DiseaseHelicobacter Pylori InfectionVonoprazan
brief summary
The primary objective is to determine the pharmacokinetics (PK) of vonoprazan in breast milk of healthy lactating women who have received vonoprazan administered once daily or vonoprazan 20 mg administered twice daily for 4 consecutive days.
started
May 7, 2024
primary completion
Sep 13, 2024
completion
Sep 19, 2024
last updated
Mar 25, 2025
official title
A Phase 1, Open-label Study to Evaluate Vonoprazan Concentrations in Breast Milk of Healthy Lactating Women Receiving Vonoprazan 20 mg Once Daily or Vonoprazan 20 mg Twice Daily
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol